当前位置：
X-MOL 学术
›
Clin. Res. Hepatol. Gastroenterolog.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Hepatotoxicity is the risk factor with gemtuzumab ozogamicin treatment in acute myelogenous leukaemia patients.
Clinics and Research in Hepatology and Gastroenterology ( IF 2.7 ) Pub Date : 2020-05-21 , DOI: 10.1016/j.clinre.2020.04.013 Sayed Aliul Hasan Abdi 1 , Shatrunajay Shukla 2 , Jasim Khan 3 , Abdulaziz Al Zahrani 4
中文翻译：
肝毒性是吉妥珠单抗 ozogamicin 治疗急性髓性白血病患者的危险因素。
更新日期：2020-05-21
Clinics and Research in Hepatology and Gastroenterology ( IF 2.7 ) Pub Date : 2020-05-21 , DOI: 10.1016/j.clinre.2020.04.013 Sayed Aliul Hasan Abdi 1 , Shatrunajay Shukla 2 , Jasim Khan 3 , Abdulaziz Al Zahrani 4
Affiliation
中文翻译：
肝毒性是吉妥珠单抗 ozogamicin 治疗急性髓性白血病患者的危险因素。
京公网安备 11010802027423号